Class certification has been approved in Atlantic County, New Jersey, for cases involving Levaquin, an antibiotic manufactured by Johnson & Johnson for bacterial infections. The plaintiffs allege that Levaquin caused tendon ruptures and tendonitis, and patients who had a transplant or were over age 60 were most commonly affected. The FDA released a warning on these reported issues in July 2008